hit counter

Language and Theory of Mind Separate by Age 3 in Child Brain Scans

MHD featured image for language and theory of mind brain development in children.

A 2026 fMRI study found language and theory-of-mind activation already separated in 54 child sessions from ages 3-9, with strict child overlap near zero in the left superior temporal lobe (Dice 0.015) and no evidence that the 2 systems disentangled with age.1 The result pushes against a simple developmental story in which language grows out …

Read more

AI Mental Status Exam Benchmark Shows Qwen3-Omni Reasoning Gap

MHD featured image for AI mental status exam benchmark and clinical reasoning gap.

A 2026 medRxiv benchmark found Qwen3-Omni reached only moderate agreement with expert mental status examination panels: AC1 = 0.70 vs. UTHealth and 0.72 vs. Yale, below expert agreement of 0.87; its aggregate performance masked a clinical reasoning gap, overcalling visible signs such as speech and affect while missing delusions and perceptual abnormalities.1 Research Highlights Expert …

Read more

LIFU vs. rTMS for Stroke Recovery: Same 2-Week Endpoint, Larger FMA Gains

MHD featured image for LIFU vs. rTMS in post-stroke motor recovery.

A 2026 secondary randomized-trial analysis found that low-intensity focused ultrasound and repetitive transcranial magnetic stimulation reached statistically similar 2-week post-treatment motor scores after subacute stroke, even though LIFU produced larger median Fugl–Meyer Assessment gains than rTMS: 7 vs. 2 upper-limb points and 3 vs. 1 lower-limb points.1 LIFU therefore carries the recovery-dynamics signal in this …

Read more

Levetiracetam Range in Children: 2.82-24.37 mcg/mL TDM

MHD featured image for levetiracetam therapeutic drug monitoring in children with epilepsy.

A 2026 real-world study involving 1,174 children with epilepsy proposed a levetiracetam therapeutic drug monitoring range of 2.82-24.37 mcg/mL, much lower than commonly cited adult-style ranges, but the same data also warned against treating a drug level as a stand-alone seizure-control predictor. Research Highlights Lower pediatric range: Sun et al. proposed an observational levetiracetam range …

Read more

Autoimmune Focal Epilepsy: Antibody Testing and Immunotherapy

MHD featured image for autoimmune drug-resistant focal epilepsy and immunotherapy.

A 2026 structured review of autoimmune drug-resistant focal epilepsy argues for a narrow but clinically important claim: immune mechanisms can make seizures refractory in selected patients, but the evidence supports targeted testing and immunotherapy triage rather than treating every medication-resistant seizure disorder as autoimmune. Research Highlights Autoimmune epilepsy is a subset: Kunecki et al. estimated …

Read more

Prostate Cancer Survivors Who Smoke Showed Lower Verbal Memory Scores

MHD featured image for smoking, verbal memory, and cognition in prostate cancer survivors.

A 2026 study involving 118 prostate cancer survivors found the clearest lifestyle-cognition signal around smoking: smokers learned fewer words across repeated verbal-memory trials, while obesity and physical activity produced narrower reaction-time findings and no significant anxiety or depression differences. Research Highlights Smoking tracked verbal learning: in 118 prostate cancer survivors, smokers scored lower on Verbal …

Read more

Multiple Sclerosis Iron MRI Linked to Cognitive Impairment in 12 Studies

MHD featured image for multiple sclerosis, iron-sensitive MRI, and cognitive impairment.

A 2026 systematic review of advanced neuroimaging in multiple sclerosis narrowed 600 database records to 12 studies and found the clearest cognition signal in basal ganglia iron-sensitive MRI measures, while thalamic susceptibility was more variable and often tangled with atrophy. Research Highlights Basal ganglia signal was strongest: across 12 studies, elevated susceptibility or iron-related metrics …

Read more